What question did this study set out to answer?

To evaluate how the timing of initial low-molecular-weight heparin prophylaxis impacts antithrombotic effectiveness and safety following elective hip arthroplasty.

September 10, 2001

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

View Full Paper

Ask AI

Bookmark

Why the study?

Does the timing of initial administration of low-molecular-weight heparin prophylaxis affect deep vein thrombosis prevention in patients following elective hip arthroplasty?

Population

Patients following elective hip arthroplasty

Comparison

Initial administration of low-molecular-weight… vs Delayed initiation of low-molecular-weight…

Design

Systematic_review

Authors

RHRussell D. HullVascular Medicine GPGraham F. PineoVascular / Pulmonary Vascular PSPaul D. SteinVascular / Pulmonary Vascular

Discussion

Member takes

Implication

Recommend early LMWH initiation after hip arthroplasty; strengthens guideline recommendations on prophylaxis timing.

Key Points

To evaluate how the timing of initial low-molecular-weight heparin prophylaxis impacts antithrombotic effectiveness and safety following elective hip arthroplasty.
Conducted a systematic review analyzing different timing regimens for initiating low-molecular-weight heparin prophylaxis in patients undergoing elective hip arthroplasty.
Initiation timing of low-molecular-weight heparin significantly determines antithrombotic effectiveness.
Delayed administration of prophylaxis leads to suboptimal antithrombotic protection without providing a substantive safety advantage.

Structured PICO

Does the timing of initial administration of low-molecular-weight heparin prophylaxis affect deep vein thrombosis prevention in patients following elective hip arthroplasty?

Population

Patients following elective hip arthroplasty

Intervention

Initial administration of low-molecular-weight heparin prophylaxis

Comparator

Delayed initiation of low-molecular-weight heparin prophylaxis

Outcome

Deep vein thrombosis (antithrombotic effectiveness)hard clinical

Delayed initiation of low-molecular-weight heparin prophylaxis after elective hip arthroplasty reduces antithrombotic effectiveness without providing a safety advantage.

Cite This Study

Hull et al. (2001) studied this question.

synapsesocial.com/papers/69dee9f3210a0977fce95c19 https://doi.org/10.1001/archinte.161.16.1952

View Full Paper

Ask AI

Bookmark

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider